Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Star Combo PharmaASX:S66 35 Forward Dividend Yield % is 2.85% as of Aug. 02, 2026. GuruFocus rates ASX:S66 with a GF Score™ of 35/100 and a GF Value™ of A$0.13 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,146 Consumer Packaged Goods companies, Star Combo Pharma ranks worse than 52.18% on this metric.
As of today (2026-08-02), the Forward Annual Dividend Yield of Star Combo Pharma is 2.85%.
As of today (2026-08-02), the Trailing Annual Dividend Yield of Star Combo Pharma is 2.85%.
ASX:S66's Forward Dividend Yield % is ranked worse than 52.18% of 1146
companies
in the Consumer Packaged Goods industry
Industry Median: 2.995
vs ASX:S66: 2.85
Star Combo Pharma (ASX:S66) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Star Combo Pharma Forward Dividend Yield % Related Terms
ASX:S66 vs PG, CL, KVUE: Forward Dividend Yield % Comparison
For the Household & Personal Products subindustry, Star Combo Pharma's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Star Combo Pharma Forward Dividend Yield % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Star Combo Pharma's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Star Combo Pharma's Forward Dividend Yield % falls into.
Star Combo Pharma Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Star Combo Pharma Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
AUD 0.003701
2025-10-14
2025-10-15
2025-10-31
Cash Dividend
annually
AUD:AUD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Star Combo Pharma's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.003701
/
0.13
=
2.85 %
Current Share Price is A$0.13. Star Combo Pharma's Dividends per Share for the forward twelve months is calculated as A$0.003701 * 1 = A$0.003701.
Star Combo Pharma's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 2.85% mean?
Star Combo Pharma (ASX:S66) has a Forward Dividend Yield % of 2.85% as of Aug. 02, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Star Combo Pharma and its competitors. According to the industry distribution chart, Star Combo Pharma ranks #598 out of 1146 companies in the Consumer Packaged Goods industry, placing it in the top 52.2%.
Is Star Combo Pharma's Forward Dividend Yield % too high?
Star Combo Pharma's current Forward Dividend Yield % is 2.85%. The Consumer Packaged Goods industry median Forward Dividend Yield % is 3.00. Star Combo Pharma's value of 2.85% is 4.8% below this industry median. Based on the distribution chart, Star Combo Pharma ranks #598 out of 1146 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Star Combo Pharma has a GF Score™ of 35/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Star Combo Pharma's Forward Dividend Yield % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Star Combo Pharma ranks #598 out of 1146 companies for Forward Dividend Yield %. This places Star Combo Pharma in the lower half of its industry. The industry median Forward Dividend Yield % is 3.00. Star Combo Pharma's value of 2.85% is 4.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Consumer Packaged Goods company?
The median Forward Dividend Yield % among Consumer Packaged Goods companies is 3.00, based on 1,146 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Star Combo Pharma's current Forward Dividend Yield % of 2.85% is 4.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Star Combo Pharma and its competitors. For the Consumer Packaged Goods industry, the median Forward Dividend Yield % is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Star Combo Pharma's current Forward Dividend Yield % is 2.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Combo Pharma stock overvalued right now?
Based on GuruFocus' analysis, Star Combo Pharma (ASX:S66) is currently considered Fairly Valued. The stock's GF Value™ is A$0.13, compared to a current price of A$0.13 — trading right at its estimated fair value. The current Forward Dividend Yield % is 2.85% and 4.8% below the Consumer Packaged Goods industry median of 3.00. Star Combo Pharma's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Star Combo Pharma (ASX:S66), the current Forward Dividend Yield % is 2.85% as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Star Combo Pharma (ASX:S66) Overvalued in 2026?
Based on GuruFocus' analysis, Star Combo Pharma stock appears to be undervalued.
The current stock price of A$0.13 is trading 0% below its estimated GF Value™ of A$0.13.
GuruFocus considers Star Combo Pharma to be Fairly Valued.
Key valuation signals for ASX:S66:
Forward Dividend Yield %: 2.85%
GF Value™: A$0.13 vs. price of A$0.13 (0% below fair value)
Industry Position: 4.8% below the Consumer Packaged Goods median (#598 of 1146)
No single metric tells the full story. See the ASX:S66 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Star Combo Pharma Ltd is engaged in the manufacturing and distribution of food products and nutritional supplements. The company offers products such as Costar, Living Healthy, Amax, and J&K. It operates in two segments. The Star Combo segment engages in the development, manufacturing, marketing, and sales of natural health supplements and skincare products. The Austoyou retail business segment consists of the Australia-China e-commerce platform that offers product lines directly to Chinese health product consumers, and Koala Mall's two retail stores in Sydney. Geographically, it operates in China and Australia.
35GF Score
Get the complete analysis for ASX:S66
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:S66 has been successfully added to your 
